BamSEC and AlphaSense Join Forces
Learn More

PTC Therapeutics Inc.

NASDAQ: PTCT    
Share price (12/23/24): $45.56    
Market cap (12/23/24): $3.514 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 9 pages ​ Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. ​ Amendment No. 1 to Amended and Restated Royalty Purchase Agreement and First Put Option Exercise Agreement ​
12/34/56
EX-10.1
from 10-Q 23 pages Amended and Restated Exclusive License and Supply Agreement
12/34/56
EX-10.1
from 10-Q 26 pages Employment Agreement
12/34/56
EX-10.48
from 10-K 51 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. ​ ​ Amended and Restated Royalty Purchase Agreement ​ by and Among ​ PTC Therapeutics, Inc., ​ Royalty Pharma Investments 2019 Icav ​ and ​ Solely for the Purposes of Section 5.15 Hereof, ​ Royalty Pharma PLC ​ Dated as of October 18, 2023 ​
12/34/56
EX-10.1
from 10-Q 4 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. ​ Amendment No. 5 to License Agreement ​
12/34/56
EX-10.1
from 8-K 24 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 55 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions
12/34/56
EX-10.1
from 10-Q 87 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions
12/34/56
EX-10.1
from 8-K 25 pages Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 8-K 9 pages Consulting Agreement
12/34/56
EX-10.56
from 10-K 36 pages Stock Purchase Agreement by and Among the Investors Listed Herein and PTC Therapeutics, Inc. Dated as of October 27, 2022
12/34/56
EX-10.55
from 10-K 154 pages Each Subsidiary of the Borrower From Time to Time Party Hereto, as Guarantors, ​ the Lenders From Time to Time Party Hereto ​ and Wilmington Trust, National Association, as Administrative Agent
12/34/56
EX-10.23
from 10-K 16 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions
12/34/56
EX-10.21
from 10-K 7 pages PTC Therapeutics, Inc. Restricted Stock Unit Agreement
12/34/56
EX-10.20
from 10-K 6 pages PTC Therapeutics, Inc. Nonstatutory Stock Option Agreement Granted Under Amended and Restated 2013 Long-Term Incentive Plan
12/34/56
EX-10.19
from 10-K 6 pages PTC Therapeutics, Inc. Nonstatutory Stock Option Agreement Granted Under Amended and Restated 2013 Long-Term Incentive Plan
12/34/56
EX-10.18
from 10-K 6 pages PTC Therapeutics, Inc. Incentive Stock Option Agreement Granted Under Amended and Restated 2013 Long-Term Incentive Plan
12/34/56
EX-10.1
from 8-K 4 pages PTC Consulting Services Agreement
12/34/56
EX-10.2
from 10-Q 2 pages ​ Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. ​ ​ ​ Confidential ​ September 14, 2022 ​ Brett Monia President Akcea Therapeutics, Inc. ​ Re: Collaboration and License Agreement Dated August 1, 2018 (The “Agreement”) Between Akcea Therapeutics, Inc. (“Akcea”) and PTC Therapeutics International Limited (“Ptc”) ​ Dear Brett: ​
12/34/56
EX-10.1
from 10-Q 2 pages ​ Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. ​
12/34/56